Elevra Lithium Ltd SEC Filings

Elevra Lithium Ltd director Armstrong Jeffrey T. has filed an initial ownership report showing a direct holding of 22,855 American Depositary Shares. Each American Depositary Share represents ten Ordinary Shares. This Form 3 filing establishes his existing stake and does not report any recent share purchases or sales.

Elevra Lithium Ltd filed an initial insider ownership report for Managing Director and CEO Dow Lucas Lindsay. The filing shows indirect beneficial ownership of 16,667 Ordinary Shares of Elevra Lithium, held through the Dow Group Investments Trust, rather than in Lindsay’s name directly.

This Form 3 does not report a new purchase or sale; it establishes the CEO’s existing equity stake and clarifies that the shares are owned via a trust structure classified as indirect ownership.

Elevra Lithium Ltd filed a Form 3 showing that Chief Financial Officer Cortes Vargas Christian Mauricio is reporting his ownership in the company. The filing lists 11,431 Ordinary Shares held directly, with no buys, sells, or derivative positions reported in this excerpt.

Elevra Lithium Ltd director Laurie Jean Lefcourt has filed an initial statement of beneficial ownership. The filing shows direct ownership of 8,154 Ordinary Shares following the reported holdings entry. This report establishes Lefcourt’s equity position in the company as a director.

Elevra Limited reports the conversion of unquoted employee incentive securities into ordinary shares. A total of 24,842 ELV ordinary fully paid shares were issued or transferred on 2 March 2026 following the exercise or conversion of ELVAM performance rights. These underlying securities are already quoted on the ASX and were satisfied by a transfer of existing shares. After this change, Elevra has 169,376,771 ordinary fully paid shares on issue, alongside 2,708,166 ELVAM performance rights and 2,723,613 ELVAN options expiring 31 December 2028.

Elevra Lithium Limited reports FY26 half-year results showing stronger pricing and merger-driven gains alongside operational challenges at its North American Lithium mine. Revenue rose to US$86M, up 8%, as the average realised spodumene price increased 34% to US$937/dmt despite concentrate production falling 7% to 96kt and sales down 20% to 92kt.

Underlying EBITDA improved to a small profit of US$1M from a US$(25)M loss, while profit after tax swung to US$74M, largely driven by a US$156M impairment reversal and merger-related accounting effects. Operating cash flow was a US$(28)M outflow after US$24M of merger costs, though NAL itself generated US$5M operating cash. Cash rose to US$81M helped by merger proceeds and equity issuance.

The completed merger of Sayona Mining and Piedmont Lithium created a larger North American hard-rock producer, with NAL Ore Reserves up 124% to 48.6Mt at 1.11% Li₂O and Moblan Mineral Resources up 30% to 121Mt at 1.19% Li₂O. Elevra kept FY26 guidance unchanged, targeting 180,000–190,000dmt of production, 170,000–190,000dmt of sales, unit operating costs of US$860–US$880/dmt sold, and US$26M of capital expenditure.

Elevra Limited filed a Form 6-K furnishing three Australian Securities Exchange announcements. The company has issued 1,407,986 ELVAM performance rights under its employee incentive scheme, which are unquoted and rank equally with existing rights in that class.

Key management personnel received part of this grant, including Lucas Dow via Dow Group Investments Trust and other senior executives. After the issue, Elevra reports 169,376,771 ELV ordinary fully paid shares on issue, alongside 2,753,451 ELVAM performance rights and 2,723,613 ELVAN options. The filing also advises that the FY26 half-year report will be released on 25 February 2026, with an investor webcast for shareholders and investors.

Elevra Limited provides an update on operations, growth plans and funding. In Q2 FY26, its North American Lithium operation produced 44,154 dry metric tonnes of concentrate and sold 66,016 tonnes, generating US$66 million revenue with unit operating costs of US$812 per tonne and cash of US$81 million at 31 Dec 2025.

The company highlights combined lithium ore reserves of 106Mt at 1.15% Li2O and measured and indicated resources of 183Mt at 1.16% Li2O, plus FY26 production guidance of 180,000–190,000 tonnes and unit operating costs of US$860–US$880 per tonne. A staged brownfield expansion at NAL targets 315,000 tonnes of annual capacity and lower costs of about US$630 per tonne, with estimated initial capex of US$270 million.

Elevra also outlines a non‑binding memorandum of understanding with Mangrove Lithium for up to 144,000 tonnes of spodumene concentrate per year over five years starting in 2028, and discusses funding options, including project finance, strategic partners and positive operating cash flow.

Elevra Limited has signed a non-binding Memorandum of Understanding with Mangrove Lithium to negotiate a future offtake agreement for spodumene concentrate from the North American Lithium operation. The potential agreement could see Elevra supply up to 144,000 tonnes per year at market-related prices, subject to a floor and ceiling.

The proposed term is five years from 2028, ramping to 144,000 tonnes per annum by 2030, representing about 46% of estimated sales volumes. A binding deal depends on Mangrove making a final investment decision before June 2027 on a lithium conversion facility in Eastern Canada and agreement on definitive terms.